CSC·AIREGEN PDRN: From Ingredient to Skincare Concept

CSC · AIREGEN / INGREDIENT & FORMULATION EDITIONPDRNA new language.A considered formula.Move from ingredient storytelling to a clear product-development brief: select the source, shape the texture and define the evidence.PDRN skincare development: sourcing, formats and formulation01 / Sourcing02 / Formats03 / Development04 / Evidence01 / TWO SOURCING CONVERSATIONSDifferent origins.Different brand briefs.We explore marine and plant-derived sourcing directions for PDRN skincare, focusing on hydration, comfort and mature-skin concepts. We use serum, cream and mask formats as starting points for collection planning.Conceptual sourcing imagery; not evidence of molecular equivalence or efficacy.MARINE / 01Marine-source directionBuild the narrative around traceability. Confirm species, source tissue, purification, impurities and batch specifications before selecting the label identity.BOTANICAL / 02Plant-derived directionVerify ingredient identity first. Plant-derived or vegan positioning requires actual INCI, composition, manufacturing and supply-chain documentation.02 / TEXTURE IS THE EXPERIENCEMake the concepttangible.Serums invite attention to spread and layering; creams to daily comfort; masks to fit and carrier compatibility. Define the use occasion before choosing the vehicle and pack.Imagery depicts unbranded format concepts, not released products.03 / FROM BRIEF TO PROTOTYPEA clearer development route.01DefineConfirm identity, source, molecular-weight distribution and supplier quality documents. Review intended-market suitability.02FormulateEvaluate dispersion, pH, rheology and preservation compatibility. Select encapsulation through formulation-specific testing.03ValidateSupport final claims with finished-product stability, packaging compatibility, tolerance and efficacy evaluation.04 / EVIDENCE BEFORE PROMISEThe story needs product evidence.Turn the desired benefit into a testable question.How should mechanism and delivery language be read?Receptor pathways, cell models or other administration routes do not directly establish topical product performance. Small particles alone do not demonstrate delivery to a target skin layer or cell; methods, controls, complete formula and endpoints matter.What belongs in a finished-product claim?Choose specific hydration, sensory or appearance claims according to applicable requirements and product evidence. Unverified absorption multipliers, medical-grade status, genetic repair or regenerative treatment promises are not product conclusions here.OEM / ODM DEVELOPMENTYour brand.Your PDRN brief.Share your market, format, sensory goals and expected quantity to define ingredient selection, prototypes and validation needs.Discuss your project ↗Further reading: CSC·AIREGEN PDRN / GlobeLink。An ingredient and product-development editorial. Concept imagery is not efficacy evidence. Formulations, ingredient identities and claims remain subject to project documentation and validation.